1345P Preliminary safety and activity of CLN-081 in NSCLC with EGFR exon 20 insertion mutations (Ins20)
Zofia Piotrowska, Danny Nguyen, Marianna Koczywas, Nishan Tchekmedyian, Myles Clancy, David Witter, Angustias Page, Leigh Zawel, Helena A. Yu
Topics & Concepts
MedicineAdverse effectInterim analysisInternal medicineOncologyPhases of clinical researchCohortChemotherapyClinical trialLung Cancer Treatments and MutationsLung Cancer Research StudiesColorectal Cancer Treatments and Studies